Shiravand Y - Search Results

1

Immune Checkpoint Inhibitors in Cancer Therapy.

Shiravand Y, Khodadadi F, Kashani SMA, Hosseini-Fard SR, Hosseini S, Sadeghirad H, Ladwa R, O'Byrne K, Kulasinghe A. Shiravand Y, et al. Curr Oncol. 2022 Apr 24;29(5):3044-3060. doi: 10.3390/curroncol29050247. Curr Oncol. 2022. PMID: 35621637 Free PMC article. Review.

2

The Pandora's box of novel technologies that may revolutionize lung cancer.

Rad HS, Rad HS, Shiravand Y, Radfar P, Arpon D, Warkiani ME, O'Byrne K, Kulasinghe A. Rad HS, et al. Among authors: shiravand y. Lung Cancer. 2021 Sep;159:34-41. doi: 10.1016/j.lungcan.2021.06.022. Epub 2021 Jul 19. Lung Cancer. 2021. PMID: 34304051 Free article. Review.

3

Understanding the tumor microenvironment in head and neck squamous cell carcinoma.

Rad HS, Shiravand Y, Radfar P, Ladwa R, Perry C, Han X, Warkiani ME, Adams MN, Hughes BG, O'Byrne K, Kulasinghe A. Rad HS, et al. Among authors: shiravand y. Clin Transl Immunology. 2022 Jun 6;11(6):e1397. doi: 10.1002/cti2.1397. eCollection 2022. Clin Transl Immunology. 2022. PMID: 35686027 Free PMC article. Review.

4

Platelet Phenotyping and Function Testing in Thrombocytopenia.

Jurk K, Shiravand Y. Jurk K, et al. Among authors: shiravand y. J Clin Med. 2021 Mar 7;10(5):1114. doi: 10.3390/jcm10051114. J Clin Med. 2021. PMID: 33800006 Free PMC article. Review.

5

A Comprehensive Overview of Coagulation Factor V and Congenital Factor V Deficiency.

Tabibian S, Shiravand Y, Shams M, Safa M, Gholami MS, Heydari F, Ahmadi A, Rashidpanah J, Dorgalaleh A. Tabibian S, et al. Among authors: shiravand y. Semin Thromb Hemost. 2019 Jul;45(5):523-543. doi: 10.1055/s-0039-1687906. Epub 2019 May 23. Semin Thromb Hemost. 2019. PMID: 31121608 Review.

6

Fine-Tuning of Platelet Responses by Serine/Threonine Protein Kinases and Phosphatases-Just the Beginning.

Shiravand Y, Walter U, Jurk K. Shiravand Y, et al. Hamostaseologie. 2021 Jun;41(3):206-216. doi: 10.1055/a-1476-7873. Epub 2021 Jun 30. Hamostaseologie. 2021. PMID: 34192779 Free article. Review.

7

Congenital factor XI deficiency, complete genotype and phenotype of two Iranian families.

Dorgalaleh A, Gholaminezhad M, Shiravand Y, Naderi M, Safa M. Dorgalaleh A, et al. Among authors: shiravand y. Blood Coagul Fibrinolysis. 2019 Dec;30(8):409-412. doi: 10.1097/MBC.0000000000000862. Blood Coagul Fibrinolysis. 2019. PMID: 31644447

8

Hemostasis critical values among Iranian clinical laboratories "National Survey of 157 Clinical Laboratories".

Dorgalaleh A, Shiravand Y, Dabbagh A, Tabibian S, Hosseini MS, Mansouri Tourghabeh H, Rashidpanah J, Narouei F, Shams M, Gholami MS, Saneei Moghaddam E, Shahreki H. Dorgalaleh A, et al. Among authors: shiravand y. Int J Lab Hematol. 2019 Dec;41(6):778-781. doi: 10.1111/ijlh.13109. Epub 2019 Sep 27. Int J Lab Hematol. 2019. PMID: 31560450

9

A large deletion, spanning exons 1 to 25 of F8 gene, and a high-titer factor VIII inhibitor, in severe hemophilia A.

Mousavi SH, Mesbah-Namin SA, Zeinali S, Jazebi M, Dabbagh A, Hosseini SMR, Zafarghandi Motlagh F, Shiravand Y, Dorgalaleh A. Mousavi SH, et al. Among authors: shiravand y. Int J Lab Hematol. 2020 Jun;42(3):e138-e140. doi: 10.1111/ijlh.13174. Epub 2020 Mar 3. Int J Lab Hematol. 2020. PMID: 32125779 No abstract available.

10

Mitofusin-2 in cancer: Friend or foe?

Ramaiah P, Patra I, Abbas A, Fadhil AA, Abohassan M, Al-Qaim ZH, Hameed NM, Al-Gazally ME, Kemil Almotlaq SS, Mustafa YF, Shiravand Y. Ramaiah P, et al. Among authors: shiravand y. Arch Biochem Biophys. 2022 Nov 15;730:109395. doi: 10.1016/j.abb.2022.109395. Epub 2022 Sep 19. Arch Biochem Biophys. 2022. PMID: 36176224 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

17 results

Search Page